Boston Scientific Corporation
US ˙ NYSE ˙ US1011371077

SecurityBSX / Boston Scientific Corporation
InstitutionTrust Point Inc.
Latest Disclosed Ownership8,766 shares
Latest Disclosed Value $ 550,079
Trust Point Inc. reports 0.71% decrease in ownership of BSX / Boston Scientific Corporation

On April 15, 2026 - Trust Point Inc. filed a 13F-HR form disclosing ownership of 8,766 shares of Boston Scientific Corporation (US:BSX) valued at $550,066 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 13, 2026 disclosing 8,829 shares of Boston Scientific Corporation. This represents a change in shares of -0.71% during the quarter. The current value of the position is $418,051 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 8,766 -63 -0.71 550 -34.60 0.0235
2026-01-13 2025-12-31 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 8,829 338 3.98 842 1.57 0.0665
2025-10-10 2025-09-30 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 8,491 582 7.36 829 -2.47 0.0669
2025-07-10 2025-06-30 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 7,909 954 13.72 850 21.11 0.0801
2025-04-17 2025-03-31 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 6,955 -3,340 -32.44 702 -23.72 0.0640
2025-01-24 2024-12-31 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 10,295 -253 -2.40 920 4.08 0.0638
2024-10-17 2024-09-30 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 10,548 -140 -1.31 884 7.29 0.0663
2024-07-24 2024-06-30 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 10,688 -748 -6.54 823 5.11 0.0660
2024-04-19 2024-03-31 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 11,436 -6,984 -37.92 783 -26.41 0.0615
2024-01-23 2023-12-31 13F BOSTON SCIENTIFIC COMMON STOCK 101137107 18,420 18,420 1,065 0.0881
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.